₨ Official source-observed price
PKR 5,823.23
1's
PKR 5,823.23 / vial/unit
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 5,823.23/ vial/unit
Price positionNear medianvs like-for-like peer median
Peer comparators1current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Paclitaxel
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01CD
- Strength
- 30 mg/5 mL
- Dosage form
- Concentrate for solution for infusion
- Pack
- 1's
- Registration no.
- 082058
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,823.23 | 2026-07-27 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
Anzatax 100 mg/16.7 mLPfizer Pakistan Limited · PKR 13,910.00Biopac 300 mg/50 mLMerixil Pharma · PKR 37,531.84Biopac 100 mg/16.7 mLMerixil Pharma · PKR 16,619.26Intaxel 100 mg (6 mg/mL)Atco Laboratories Limited · PKR 18,587.73Intaxel 260 mg (6 mg/mL)Atco Laboratories Limited · PKR 35,729.76Intaxel 300 mg (6 mg/mL)Atco Laboratories Limited · PKR 41,977.31Intaxel 30 mg (6 mg/mL)Atco Laboratories Limited · PKR 6,122.53Intaxel 150 mg (6 mg/mL)Atco Laboratories Limited · PKR 25,196.71
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 082058MedInfoBase. (2026). Biopac 30 mg/5 mL Concentrate for solution for infusion (1's), Merixil Pharma — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/biopac-30-mg-5-ml-082058-1s-merixil-pharma/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 082058.
MedInfoBase. Biopac 30 mg/5 mL Concentrate for solution for infusion (1's), Merixil Pharma — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/biopac-30-mg-5-ml-082058-1s-merixil-pharma/ Data observed 7 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 082058.
MedInfoBase (2026) Biopac 30 mg/5 mL Concentrate for solution for infusion (1's), Merixil Pharma — registration and price record. Available at: https://medinfobase.com/brand/biopac-30-mg-5-ml-082058-1s-merixil-pharma/ (Accessed: 23 September 2026).
"Biopac 30 mg/5 mL Concentrate for solution for infusion (1's), Merixil Pharma — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/biopac-30-mg-5-ml-082058-1s-merixil-pharma/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Biopac 30 mg/5 mL Concentrate for solution for infusion (1's), Merixil Pharma — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/biopac-30-mg-5-ml-082058-1s-merixil-pharma/.
Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.